.css-1xsl8rf{width:100%;display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-align-items:center;-webkit-box-align:center;-ms-flex-align:center;align-items:center;position:relative;overflow:hidden;background:var(--alert-bg);-webkit-padding-start:var(--chakra-space-4);padding-inline-start:var(--chakra-space-4);-webkit-padding-end:var(--chakra-space-4);padding-inline-end:var(--chakra-space-4);padding-top:var(--chakra-space-1);padding-bottom:var(--chakra-space-1);--alert-fg:var(--chakra-colors-orange-600);--alert-bg:var(--chakra-colors-orange-100);font-weight:var(--chakra-fontWeights-semibold);padding-left:var(--chakra-space-4);}.chakra-ui-dark .css-1xsl8rf:not([data-theme]),[data-theme=dark] .css-1xsl8rf:not([data-theme]),.css-1xsl8rf[data-theme=dark]{--alert-fg:var(--chakra-colors-orange-200);--alert-bg:rgba(251, 211, 141, 0.16);}@media screen and (min-width: 48em){.css-1xsl8rf{padding-left:var(--chakra-space-8);}}Bitte aktivieren Sie Javascript um alle Funktionen nutzen zu können und ihre Nutzererfahrung zu verbessern.

Dr. Alexandra Herrmann

Gräfelfing / DE

Immunic AG

Vortrag

28.03.2023
Poster
P 022
Preclinical development of optimized DHODH inhibitors as broad-spectrum antivirals for the treatment of respiratory virus infections
Antiviral therapy and resistance, Host cell factors and modulation

Weitere Beteiligungen

28.03.2023
Poster
P 104
Characterization of monkeypox virus from Franconia (Bavaria, Germany) and antiviral testing of patient isolates
Antiviral therapy and resistance, Emerging viruses and zoonosis
28.03.2023
Poster
P 230
SARS-CoV-2 ORF3c suppresses the induction of IFN-β
SARS-CoV-2, Viral pathogenesis and persistence
28.03.2023
Poster
P 022
Preclinical development of optimized DHODH inhibitors as broad-spectrum antivirals for the treatment of respiratory virus infections
Antiviral therapy and resistance, Host cell factors and modulation
28.03.2023
Poster
P 260
Generation of SARS-CoV-2 Bacmids containing large fragments of Omicron as a new strategy to analyse its pathology and virulence
SARS-CoV-2, Viral replication strategies 1 (RNA viruses)
30.03.2023
09:00 – 09:15 12 Min. 3 Min.
Abstract Talk
O 075
Gammaherpesviral tegument proteins inhibit the DNA damage response and target SMC proteins
Host cell factors and modulation, Viral transformation and oncogenesis
30.03.2023
09:45 – 10:00 12 Min. 3 Min.
Abstract Talk
O 084
Selective small molecules directed to nuclear receptor RORγ isoform 1 exhibit a broad antiviral potential through metabolic restriction of virus replication
Antiviral therapy and resistance, Host cell factors and modulation
30.03.2023
14:30 – 14:45 12 Min. 3 Min.
Abstract Talk
O 089
2'-O-methylation of SARS-CoV-2 RNA regulates innate immune sensing by MDA5
Innate immunity, SARS-CoV-2